drugset / Trial / NCT04662801

Weight Regain Treatment Post-Bariatric Surgery

NCT04662801

Non-randomizedSequentialSingle-blindTreatment

Summary

This study will examine behavioral and pharmacologic (Naltrexone+Bupropion) treatments for weight regain after bariatric surgery.

Timeline

Start
2021-08-05
Primary completion
2022-09-13
Completion
2022-09-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule
Subject Naltrexone Small molecule

Indications